Latvia vs Türkiye: Breast cancer screening coverage in Europe
Latvia
30.2%
in 2022
Türkiye
30.6%
in 2022
Latvia rank
21st
Türkiye rank
20th
Breast cancer screening coverage in Europe over time
- Latvia
- Türkiye
How they compare
Türkiye currently reports 30.6% against 30.2% in Latvia, a difference of 0.4%.
The two have swapped places 3 times across 10 shared years of data; in 2013 it was Latvia ahead.
Latvia ranks 21st and Türkiye ranks 20th of 26 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.8% | 32.7% | 4.1% | Latvia |
| 2020s | 30.3% | 26.0% | 4.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Latvia or Türkiye?
- Türkiye, at 30.6% against 30.2% in Latvia as of 2022.
- What is the difference in breast cancer screening coverage in europe between Latvia and Türkiye?
- 0.4%, with Türkiye ahead.
- How many years of comparable data are there for Latvia and Türkiye?
- 10 years are reported by both, from 2013 to 2022.
- How do Latvia and Türkiye rank globally for breast cancer screening coverage in europe?
- Latvia ranks 21st and Türkiye ranks 20th of 26 countries.
- Where does this data come from?
- Eurostat (2024) – processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.